En Es
Categorías

FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variet ...
Miembro Oro
Productos Covid-19Resumen
Close

Covid-19 FUJIREBIO

Laboratorio clínico

Flu A/B & SARS-CoV-2 Real-Time RT-PCR Test
DiaPlexQ Flu A/B & SARS-CoV-2

DiaPlexQ Flu A/B & SARS-CoV-2 is a Real-time RT-PCR test for the qualitative detection of HA gene from Influenza A/B virus and N and ORF1a gene from SARS-CoV-2 in nasopharyngeal swab.
Mas detalles

PRUEBA DE RT-PCR SARS-COV-2 (ORF1A, N, RDRP)
DiaPlexQ SARS-CoV-2 (ORF1a, N, RdRp)

DiaPlexQ SARS-CoV-2 (ORF1a, N, RdRp) es una prueba de RT-PCR en tiempo real para la detección cualitativa de ácidos nucleicos de SARS-CoV-2 en varios tipos de muestras.
Mas detalles

PRUEBA AUTOMATIZADA DE PROCALCITONINA (PCT)
Lumipulse G B•R•A•H•M•S PCT

Los cartuchos de inmunorreacción Lumipulse G BRAHMS PCT son para uso de diagnóstico in vitro (IVD) con el método de inmunoensayo sándwich de dos pasos en el sistema LUMIPULSE G para la determinación cuantitativa de procalcitonina (PCT).
Mas detalles

ENSAYO RT-ISOTÉRMICO FLUORESCENTE COVID-19
iAMP COVID-19 SANO Assay

El iAMP COVID-19 SANO es un ensayo RT-isotérmico fluorescente en tiempo real basado en la tecnología de amplificación isotérmica patentada de Atila, destinada a la detección cualitativa de ácido nucleico del SARS-CoV-2.
Mas detalles

SARS-CoV-2 S-IgG Antibody Assay
Lumipulse G SARS-CoV-2 S-IgG

Lumipulse G SARS-CoV-2 S-IgG is an assay system, including a set of immunoassay reagents, for the quantitative measurement of IgG-type antibodies SARS-CoV-2 spike protein (SARS-CoV-2 S-IgG) in specimens based on CLEIA technology. The CE marked assay system has a specific two-step immunoassay method and runs on the LUMIPULSE G System with results available in up to 30 minutes.
Mas detalles

PRUEBA DE ANTICUERPOS SARS-COV-2
Lumipulse G SARS-CoV-2 Ag

La prueba Lumipulse G SARS-CoV-2 Ag fue diseñada para uso diagnóstico in vitro (IVD) con el sistema Lumipulse G para la detección y medición cuantitativa del antígeno SARS-CoV-2 en hisopados nasofaríngeos o saliva humana.
Mas detalles

SARS-CoV-2 Ag Controls
Lumipulse® SARS-CoV-2 Ag Controls

The CE marked Lumipulse® SARS-CoV-2 Ag Controls are intended for use as an assayed quality control material to monitor the precision of laboratory testing procedures for the analysis of SARS-CoV-2 antigen on the LUMIPULSE G System.
Mas detalles

BNP Control
Lumipulse® BNP Control

The CE marked Lumipulse® BNP Control are intended for use as an assayed quality control to monitor the precision of laboratory testing procedures for the analysis of human B-type natriuretic peptide (BNP) on the LUMIPULSE G Systems.
Mas detalles

AMH Immunoreaction Cartridges
Lumipulse® G AMH (anti-Müllerian hormone)

The CE marked Lumipulse® G AMH (anti-Müllerian hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the fully automated quantitative measurement of AMH in specimens based a two-step immunoassay method on the LUMIPULSE G System. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
Mas detalles

LH Immunoreaction Cartridges
Lumipulse® G LH (Luteinizing Hormone)

The CE marked Lumipulse® G LH (Luteinizing Hormone) immunoreaction cartridges are intended for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of luteinizing hormone (LH) in serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.
Mas detalles

HIV p24 Antigen Test
INNOTEST® HIV Antigen mAb

The CE marked INNOTEST® HIV Antigen mAb is an enzyme immunoassay for the qualitative detection of HIV p24 antigen in human serum, plasma, and cell culture supernatant. The kit contains reagents for confirmation of HIV p24 antigens in repeatedly reactive samples.
Mas detalles

COVID-19 Test
iAMP COVID-19 Detection Kit

The CE marked iAMP COVID-19 Detection Kit is designed for the qualitative nucleic acid detection of SARS-CoV-2 (COVID-19) on naso- or oropharyngeal swabs without pre-treatment. Using isothermal amplification with real time fluorescence detection, the kit requires limited hands-on time and delivers fast sample-to-result within 75 to 90 minutes only.
Mas detalles

SARS-CoV-2 Assay
ESPLINE® SARS-CoV-2

The CE marked ESPLINE® SARS-CoV-2 is a cassette-style immunochromatographic assay for in vitro diagnostic (IVD) use for the detection of SARS-CoV-2 antigen directly from nasopharyngeal swab fluid. It can detect SARS-CoV-2 within 30 minutes using a simple procedure without any special instruments and is intended for use as an aid in the diagnosis of SARS-CoV-2 infection.
Mas detalles
Close

Sobre FUJIREBIO

Fujirebio is a global leader in the field of IVD testing with more than 50 years’ experience in the conception, development, production and worldwide commercialization of robust IVD products. These span the range from specialized testing to fully automated routine clinical laboratory testing solutions covering a variety of disease states.
Facebook Twitter Google+ Linked in
HTLV-I/II Immunoreaction Cartridges

HTLV-I/II Immunoreaction Cartridges

Modelo: Lumipulse G HTLV-I/II
Solicite información

Descripción:

The CE marked Lumipulse G HTLV-I/II immunoreaction cartridges is meant for in vitro diagnostic use with the LUMIPULSE G System for qualitative detection of antibody to HTLV-I and HTLV-II in human serum or plasma for screening of HTLV-I/II viral infection.
Más info

Descripción completa

Descripción

The CE marked Lumipulse G HTLV-I/II immunoreaction cartridges is meant for in vitro diagnostic use with the LUMIPULSE G System for qualitative detection of antibody to HTLV-I and HTLV-II in human serum or plasma for screening of HTLV-I/II viral infection. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme ImmunoAssay) technology with results that are available in up to 35 minutes. Solicite información

Enviar un mensaje al proveedor

* Información requerida
* Email:
Para
FUJIREBIO ()
* Mensaje

Derecho de autor © 2000-2022 TradeMed.com. Todos los derechos reservados. | Términos y condiciones